About Us
Brands in Conversation
Academic Connect
Marketing Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Sunday, October 4, 2026
Sign in / Join
Home
Disclaimer
Facebook
Instagram
Linkedin
X
WhatsApp
About Us
Brands in Conversation
Academic Connect
Marketing Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Home
Tags
USFDA approval
Tag: USFDA approval
Brands in Conversation
Zydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-Days CGT exclusivity
Author
-
August 5, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dapsone Gel, 5%
Author
-
June 29, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Oseltamivir Phosphate for Oral Suspension
Author
-
June 26, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Levothyroxine Sodium Tablets
Author
-
May 22, 2026
0
Brands in Conversation
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Passionate in Marketing
-
November 15, 2025
0
Brands in Conversation
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Passionate in Marketing
-
November 14, 2025
0
Brands in Conversation
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets
Passionate in Marketing
-
August 19, 2025
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
Author
-
July 28, 2025
0
Brands in Conversation
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg
Author
-
July 16, 2025
0
Brands in Conversation
Zydus Receives Final Approval From USFDA For Glatiramer Acetate Injection, The Generic Version Of Copaxone® 20 Mg/Ml, 40 Mg/Ml, Single-Dose Prefilled Syringes
Author
-
May 9, 2025
0
1
2
Page 1 of 2